Business Standard
Saturday, Feb 18, 2012
drived banner
drived banner
  Advanced Search
RSS
Content Guide
Follow us on  
||||Economy & Policy||||| 
 Section Home | News Now | Today's Paper | Features & Analysis | Politics & Public Affairs | Q&A | Columnists | BS Says
Home > Economy & Policy Live Markets | Commodities
 

UK keen on strong bonds with Indian drug controllers for quality
BS Reporter / Chennai/ Bangalore Sep 19, 2009, 00:09 IST

The United Kingdom (UK), which prides itself in being a major centre for drug research, has great interest in building up a strong relationship with the Drug Controller General of India.

This is not because India is considered a major centre for drug research, but, because about one-fourth of the volume of generic drugs sold in UK are those imported from India.

About two-thirds of the products sold in the UK are generic. “That’s why we are interested in building up a strong relationship with the Drug Controller of India and the respective drug controllers in the major states,” said Gerald W Heddell, director, inspection enforcement and standards division, Medicines and Healthcare Products Regulatory Authority, UK.

The UK’s centralised healthcare system, National Health Service (NHS), is the world’s biggest health service. UK is interested in ensuring that they have only quality products being imported.

The UK government wants strong links with the Indian regulators. That is one reason why Indian drug producing companies are also of great importance for the UK.

A team from the UK was in India to exchange information with the Drugs Controller of India and also some of the state drug controllers.

Meanwhile, the UK, which has great strength in clinical research, is trying to attract clinical research firms from India to set up labs or for doing clinical research in the UK. It is also keen on promoting itself as a drug manufacturing centre.

According to a report from Ernst & Young 2007, UK was the leader in biotech sector in Europe with 40 per cent of EU’s public biotech companies.

The UK has established end-to-end capability in bringing products to market.

It accounts for about 35 per cent of the European drugs in clinical trial pipeline. In the UK, the government funding for clinical research is expected to rise to 1.7 billion pounds per annum by 2010.

New Ipad Application :Business Standard's all new IPad App
Click here to download for free
Arrow Other Stories     
- Wall Street up on Greece, but gains seen limited
- Civic polls: Saffron alliance retains Mumbai, Thane
- MCX awaits trading rules in commodity options, indices
- Govt to provide incentives for electronic chip manufacturing
- Sure to buy French Rafale jets: Indian Air Force
  Read Business news in 
- Now property search gets more exciting than ever before!
- High Growth Business Opportunities in Africa - Register to explore
- Medium-sized businesses are the engines of a smarter planet.
- Office 365 for professionals and small businesses.
- Earn fuel worth Rs.2400 with Citi
- India's No. 1 Property Site. Click here to know more..
- Diseases earlier, Saving Costs, Extending Lives. Know More..
- Get 5% cashback on telephone bills with Citi
- Enjoy the journey as much as the destination. click to know more..
- Exim Bank Conclave on India - Africa Project Partnership. Know more..
- Creating Wealth made simple the SIP way. Know more..
- Only Developer to give a guarantee on time space & rate.
- Buy Your Property with Our Triple Guarantee in India.
- Improve Patient Care & Experience. Click here to know more
- Win a Business Class Ticket to Europe..Know more..
-  Introduce a New Automotive Luxury Car.. know more
Sorry, comments to this story are closed
Latest Messages
SmartInvestor+ E-zine
  Pay Rs.747/- for 3 years and
  get a branded watch FREE

  Subscribe Now
Most Popular
Read
E-Mailed
Commented
   
- The malt of India
- The painter of a dream world
- Kishore Singh: Keeping up with the Bengali
- Umair Javed: A sterile, earnest sea breeze
- The luxury merchants
 
 More  
New Ipad Application
 Business Standard's all new IPad  App
 Click here to download for free
  BS Specials  
    Full coverage of elections in Uttar Pradesh, Punjab, Uttarakhand, Manipur and Goa
  Hot Searches  
 
IRFC bond |  Antrix-Devas |  Rafale fighter |  Junglee |  IPL 5 |  Dhanlaxmi Bank |  Thomas Cook |  TCS |  Sarfaesi Act |  Vodafone |  Aakash tablet |  Sodexo |  Rupee |  Samsung Galaxy Note |  Kingfisher Airlines |  Silver |  Provident Fund |  income tax refund |  Anna Hazare |  iPhone |  Reliance Industries |  SEBI |  BSNL |  BSE |  NSE |  Mukesh Ambani |  Anil Ambani |  Infosys |  Pranab Mukherjee |  Sonia Gandhi |  Rahul Gandhi |  New Pension Scheme |  Reliance |  RBI |  GDP |  Gold |  Ratan Tata |  ICICI |  B-School |  Sensex |  Tax calculator |  Home Loan |  Personal Finance |  inflation |  oil prices |  Barack Obama |   
 
  Member Area Write to the Editor RSS Archives Advanced Search
  Subscribe to BS print product BS e-paper Newsletter Portfolio Tracker
  BS Products BS Hindi BS Motoring BS Books
FOR HOT PRODUCTS
BS Bazaar.com
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Contact Us